[go: up one dir, main page]

NO20005796L - Nye forbindelser av 12,13-(pyranosyl)-indolo[2,3- a]pyrrolo[3,4-c]karbazol og 12,13-(pyranosyl)-furo[3,4-c]indolo[2,3-a]karbazol, fremgangsmåte ved deres fremstilling ogfarmasöytiske sammensetninger inneholdende dem - Google Patents

Nye forbindelser av 12,13-(pyranosyl)-indolo[2,3- a]pyrrolo[3,4-c]karbazol og 12,13-(pyranosyl)-furo[3,4-c]indolo[2,3-a]karbazol, fremgangsmåte ved deres fremstilling ogfarmasöytiske sammensetninger inneholdende dem

Info

Publication number
NO20005796L
NO20005796L NO20005796A NO20005796A NO20005796L NO 20005796 L NO20005796 L NO 20005796L NO 20005796 A NO20005796 A NO 20005796A NO 20005796 A NO20005796 A NO 20005796A NO 20005796 L NO20005796 L NO 20005796L
Authority
NO
Norway
Prior art keywords
indolo
carbazole
alkyl
nrarb
aryl
Prior art date
Application number
NO20005796A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005796D0 (no
Inventor
Michelle Prudhomme
Pascale Moreau
Fabrice Anizon
Christelle Marminon
Ghanem Atassi
Alain Pierre
Bruno Pfeiffer
Pierre Renard
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO20005796D0 publication Critical patent/NO20005796D0/no
Publication of NO20005796L publication Critical patent/NO20005796L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
NO20005796A 1999-11-17 2000-11-16 Nye forbindelser av 12,13-(pyranosyl)-indolo[2,3- a]pyrrolo[3,4-c]karbazol og 12,13-(pyranosyl)-furo[3,4-c]indolo[2,3-a]karbazol, fremgangsmåte ved deres fremstilling ogfarmasöytiske sammensetninger inneholdende dem NO20005796L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9914433A FR2801054B1 (fr) 1999-11-17 1999-11-17 Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
NO20005796D0 NO20005796D0 (no) 2000-11-16
NO20005796L true NO20005796L (no) 2001-05-18

Family

ID=9552202

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005796A NO20005796L (no) 1999-11-17 2000-11-16 Nye forbindelser av 12,13-(pyranosyl)-indolo[2,3- a]pyrrolo[3,4-c]karbazol og 12,13-(pyranosyl)-furo[3,4-c]indolo[2,3-a]karbazol, fremgangsmåte ved deres fremstilling ogfarmasöytiske sammensetninger inneholdende dem

Country Status (23)

Country Link
US (1) US6569858B2 (xx)
EP (1) EP1101770B1 (xx)
JP (1) JP3602050B2 (xx)
KR (1) KR100453980B1 (xx)
CN (1) CN1152040C (xx)
AT (1) ATE237625T1 (xx)
AU (1) AU771584B2 (xx)
BR (1) BR0005426A (xx)
CA (1) CA2325779C (xx)
DE (1) DE60002142T2 (xx)
DK (1) DK1101770T3 (xx)
EA (1) EA004737B1 (xx)
ES (1) ES2197061T3 (xx)
FR (1) FR2801054B1 (xx)
HK (1) HK1036991A1 (xx)
HU (1) HUP0004574A3 (xx)
MX (1) MXPA00010899A (xx)
NO (1) NO20005796L (xx)
NZ (1) NZ508231A (xx)
PL (1) PL343879A1 (xx)
PT (1) PT1101770E (xx)
SI (1) SI1101770T1 (xx)
ZA (1) ZA200006729B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6677450B2 (en) * 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6653290B2 (en) 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
BR0208322A (pt) 2001-03-22 2004-10-13 Bristol Myers Squibb Co Derivados de açúcar citotóxixo seletivo da topoisomerase i de indolopirrolocarbazóis
FR2826653B1 (fr) * 2001-06-29 2005-10-14 Servier Lab Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2831169B1 (fr) * 2001-10-22 2003-12-12 Servier Lab Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
CN104031052B (zh) * 2014-05-20 2016-06-08 中国科学院南海海洋研究所 抗生素Indimicins A–E及其制备方法和在制备抗肿瘤药物中的应用
US10513515B2 (en) 2017-08-25 2019-12-24 Biotheryx, Inc. Ether compounds and uses thereof
EP3830093A1 (en) 2018-07-27 2021-06-09 Biotheryx, Inc. Bifunctional compounds as cdk modulators
RU2726801C1 (ru) * 2019-10-16 2020-07-15 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Блохина" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Блохина" Минздрава России) Средство для терапии опухолей
EP4143329A4 (en) 2020-04-28 2024-10-16 Anwita Biosciences, Inc. Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015578A (en) * 1989-03-23 1991-05-14 Bristol-Myers Squibb Company BMY-41950 antitumor antibiotic
JPH05140168A (ja) * 1991-11-13 1993-06-08 Asahi Chem Ind Co Ltd インドロカルバゾール誘導体及び該化合物を有効成分とする抗腫瘍剤
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
JPH07112987A (ja) * 1993-10-14 1995-05-02 Asahi Chem Ind Co Ltd スタウロスポリン糖部分変換誘導体
CO4940430A1 (es) * 1997-07-07 2000-07-24 Novartis Ag Compuestos policiclicos que contienen estaurosporina hidrogenada con propiedades farmacologicas convenientes y un efecto inhibidor sobre el crecimiento de las celulas tumorales

Also Published As

Publication number Publication date
AU7168100A (en) 2002-01-03
EP1101770A1 (fr) 2001-05-23
HUP0004574A3 (en) 2001-12-28
US6569858B2 (en) 2003-05-27
CA2325779A1 (fr) 2001-05-17
JP2001139578A (ja) 2001-05-22
AU771584B2 (en) 2004-03-25
EA200001078A1 (ru) 2001-06-25
FR2801054A1 (fr) 2001-05-18
FR2801054B1 (fr) 2003-06-13
PT1101770E (pt) 2003-07-31
BR0005426A (pt) 2001-07-03
US20020055510A1 (en) 2002-05-09
HU0004574D0 (xx) 2001-02-28
DE60002142D1 (de) 2003-05-22
CN1303859A (zh) 2001-07-18
ES2197061T3 (es) 2004-01-01
JP3602050B2 (ja) 2004-12-15
PL343879A1 (en) 2001-05-21
ZA200006729B (en) 2001-06-05
HK1036991A1 (en) 2002-01-25
SI1101770T1 (en) 2003-08-31
KR100453980B1 (ko) 2004-10-20
DK1101770T3 (da) 2003-08-04
ATE237625T1 (de) 2003-05-15
CN1152040C (zh) 2004-06-02
EA004737B1 (ru) 2004-08-26
MXPA00010899A (es) 2002-05-23
NO20005796D0 (no) 2000-11-16
CA2325779C (fr) 2006-07-11
DE60002142T2 (de) 2004-03-18
EP1101770B1 (fr) 2003-04-16
KR20010051775A (ko) 2001-06-25
HUP0004574A2 (hu) 2001-10-28
NZ508231A (en) 2001-09-28

Similar Documents

Publication Publication Date Title
NO20005796L (no) Nye forbindelser av 12,13-(pyranosyl)-indolo[2,3- a]pyrrolo[3,4-c]karbazol og 12,13-(pyranosyl)-furo[3,4-c]indolo[2,3-a]karbazol, fremgangsmåte ved deres fremstilling ogfarmasöytiske sammensetninger inneholdende dem
DK1159279T3 (da) 4-Oxo-4,7-dihydro-thieno[2,3-b]pyridin-5-carboxamider som antivirale midler
FI900307A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivista 3-/3-okso-(2,3)-dihydropyridatsin-6-yyli/-2-fenyyli-pyratsolo/1,5-a/pyridiinijohdannaisia
FI913446A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivista 3-(2-substituoitu-3-okso-2,3-dihydropyridatsin-6-yyli)-2-fenyylipyratsolo/1,5-a/pyridiinejä
NO943682L (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
ATE247118T1 (de) Imidazo(1,2-a)(pyrrolo, thieno oder furano)(3,2- d)azepinderivate, zubereitungen und ihre verwendung
HUT47580A (en) Process for production of tricycle oxindole derivatives decreasing inflammation
ES2115608T3 (es) Procedimiento para preparar derivados lactamicos.
IL112102A0 (en) Annelated dihydropyridinoacetic acid derivatives, their preparation and pharmaceutical compositions containing them
FI881889A0 (fi) Menetelmä valmistaa farmaseuttisesti käyttökelpoista bentso-3,4-dihydropyridiinin johdosta
FI910126L (fi) Menetelmä farmaseuttisesti käyttökelpoisen 4-(5,6,7,8-tetrahydroimidatso/1,5-a/pyridin-5-yyli)-bentsonitriilin hydrokloridin valmistamiseksi kiteisessä hemihydraattimuodossa
NO20000605L (no) 3-Substituerte 3,4,5,7-tetrahydro-pyrrolo[3',4':4,5]tieno[2,3- D]pyrimidinderivater, deres fremstilling og anvendelse som 5HT- antagonister
KR920004390A (ko) 피롤로벤조이미다졸, 이미다조벤족사지논 및 이미다조퀴놀론, 이들의 제조방법, 이들의 용도 및 이 화합물들을 함유하는 제제
BG108423A (en) Dihydroimidazo[5,1-a]beta-carboline derivatives, method for preparing same and use thereof as medicine
KR950032205A (ko) 5,6-디 히드로-4H-티에노 [3,4-c] 피롤유도체, 그것의 제조방법 및 치료에의 이용
FR2767132B1 (fr) Nouveaux composes de bis pyrido [4,3-b] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
NO922812L (no) Naftyridin- og kinolizinderivater og farmasoeytiske preparater inneholdende disse
WO2000034286A3 (en) Process for the preparation of pyrimidinone derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application